Belfast needle exchange closure cuts off a low-barrier route into care
A Belfast needle exchange that has functioned as a frontline harm-reduction service is due to close within days after losing its city centre premises. The loss lands hard for people who inject heroin or cocaine, because the exchange has done far more than hand out sterile needles: it has offered wound care, safe disposal, advice on temporary accommodation, and a place where service users can ask for help without being judged.
The closure is scheduled for 2 November, after which the charity Extern will move to a significantly reduced street-based service. In practical terms, that means one of the city centre’s most accessible points of contact for people at high risk from blood-borne infection, soft tissue injury, and overdose-related harm will no longer operate from a fixed site.
The service has been described as life-saving, and the language is not exaggerated. Needle exchanges lower risk in a population that often has unstable housing, poor health, interrupted access to primary care, and limited trust in formal services. When sterile equipment is easy to obtain and used needles can be returned safely, the odds of transmission of hepatitis B, hepatitis C, and HIV fall; abscesses and cellulitis are also less likely to be missed until they become severe. The same setting can also be the first doorway into treatment, vaccination, or social support.
One service user captured the emotional and clinical value of that continuity in a single sentence: the exchange was not only about equipment, but about the people who work there. That is the part systems often lose when a service moves from a stable site to a diminished outreach model. Trust is cumulative, and for people who live with addiction and isolation, a familiar room and familiar staff can be the difference between coming back for help or disappearing from care altogether.
Needle return numbers point to the scale of local dependence
The closure comes at a time when Extern says cocaine use is believed to be rising in Belfast city centre. The charity said it suspects there are between 1,000 and 1,500 people at any one time experiencing difficulties with drug use. Those figures are not a census of the city’s drug-using population, but they do indicate a sizeable and unstable group for whom contact with health services may already be fragmented.
Last year, almost 20,000 used needles were returned by people attending the Royal Avenue premises. Extern’s city centre outreach team also removed more than 13,000 discarded needles from Belfast streets, an increase of roughly 20% from previous years. Those figures matter because they reveal two parallel realities: a concentrated demand for sterile equipment and a visible public health burden when safe disposal is unavailable or underused.
A needle exchange is often judged too narrowly by counting syringes distributed. In reality, each exchange visit can include a brief wound assessment, overdose prevention advice, referral to temporary accommodation, discussion of safer injecting technique, and a chance to identify the early signs of serious infection. For a person injecting in a chaotic setting, that may be the only health contact they have that week.
The site’s impending closure is also tied to redevelopment of the building as part of the Belfast Stories project. Extern has spent more than a year searching for another city centre location, with support from Belfast City Council, the Public Health Agency, the Department of Health, and landlords. No replacement site has yet been secured. A fixed, centrally located service cannot be replaced one conversation at a time once the premises are gone.
Reduced access could intensify visible harm in the city centre
Extern has warned that the loss of a premises may push more substance use into public view and increase drug-related litter. That risk is not abstract. When a supervised or semi-supervised site disappears, people still inject somewhere; they simply lose a place where equipment can be obtained, wounds can be dressed, and used needles can be returned rather than discarded in stairwells, alleys, or public toilets.
Public-facing harm reduction is sometimes misunderstood as enabling drug use. The clinical reality is more direct: it reduces the burden of infection, injury, and public exposure to contaminated sharps while keeping a vulnerable population connected to services that can escalate care when needed. The absence of that bridge tends to show up later as more emergency attendance, more untreated abscesses, more discarded needles, and more people arriving in crisis instead of earlier in the course of illness.
Paul McCusker, an independent councillor who has campaigned on homelessness, poverty, and addiction, said the closure would place vulnerable people at even greater risk. He described a drug epidemic in Belfast that has outpaced the political response and warned that fears and misconceptions about needle exchanges need to be challenged. His comments reflect a familiar public health problem: the most effective interventions are often the least visible, while the most visible harms are the result of failing to keep those interventions in place.
The Public Health Agency’s commissioning data show how heavily such services are used across Northern Ireland. In 2024-2025, the Enhanced Needle and Syringe Exchange Service recorded 32,667 transactions, up 7.4% on the previous year. About 721,000 needles and syringes were distributed, a 7.5% increase year on year. Those figures point to steady and expanding dependence on low-threshold access, particularly in areas with established injecting behaviour.
Needle exchanges are located where they are needed because people who inject drugs are often in poor health, dealing with complex social problems, and may have no reliable access to sterile equipment or advice. The PHA said those services are particularly valuable because they may be the only services people are willing to use, and because they create opportunities to direct them toward additional support and information. When a site closes, the system does not lose a shopfront alone; it loses a point of clinical contact that has already proven its worth in real-world use.
The unresolved issue is where that access will come from next, and how quickly a replacement can be secured before the reduced street-based model is forced to carry a demand it was never designed to absorb.